CIK 0001505497 · Non-accelerated filer<br>Smaller reporting company
BioRestorative Therapies, Inc.
Sign in to watch- Ticker
- BRTX
- Exchange
- Nasdaq
- Industry
- Services-Misc Health & Allied Services, NEC
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 301341024
- Phone
- (631) 760-8100
- Business address
- 40 MARCUS DRIVE, SUITE ONE, MELVILLE, NY
- Former names
- Stem Cell Assurance, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2014-02-18 | Radov A. Jeffrey Director | Grant or award · Stock Option | +500,000 | 500,000 | ||
| 2013-12-30 | Westbury Trust 10% owner | Other acquisition · Common Stock Warrants (right to buy) | +800,000 | 800,000 | ||
| 2013-12-30 | Westbury Trust 10% owner | Option exercise | +400,000 | $0.30 | $120K | 1,715,000 |
| 2013-12-30 | Westbury Trust 10% owner | Option exercise | +400,000 | $0.30 | $120K | 2,115,000 |
| 2013-12-30 | Westbury Trust 10% owner | Other disposition · Common Stock Warrants (right to buy) | −400,000 | 0 | ||
| 2013-12-30 | Westbury Trust 10% owner | Other acquisition · Common Stock Warrants (right to buy) | +400,000 | 400,000 | ||
| 2013-12-30 | Westbury Trust 10% owner | Option exercise · Common Stock Warrants (right to buy) | −400,000 | 0 | ||
| 2013-12-30 | Westbury Trust 10% owner | Other disposition · Common Stock Warrants (right to buy) | −400,000 | 0 | ||
| 2013-12-30 | Westbury Trust 10% owner | Other acquisition · Common Stock Warrants (right to buy) | +400,000 | 400,000 | ||
| 2013-12-30 | Westbury Trust 10% owner | Option exercise · Common Stock Warrants (right to buy) | −400,000 | 0 | ||
| 2013-12-26 | Silva Francisco VP of Research and Development | Purchase | +100 | $10.40 | $1K | 150 |
| 2013-10-04 | Silva Francisco VP of Research and Development | Grant or award · Stock Option | +100,000 | 100,000 | ||
| 2013-10-04 | Weinreb Mark CEO and Chairman of the Board | Grant or award · Stock Option | +250,000 | 250,000 | ||
| 2013-10-04 | Radov A. Jeffrey Director | Grant or award · Stock Option | +250,000 | 250,000 | ||
| 2013-10-04 | Clark Mandy D. VP of Operations | Grant or award · Stock Option | +80,000 | 80,000 | ||
| 2013-10-04 | San Antonio Joel Director | Grant or award · Stock Option | +250,000 | 250,000 | ||
| 2013-07-17 | Silva Francisco VP of Research and Development | Purchase | +50 | $10.40 | $520 | 50 |
| 2012-12-07 | Clark Mandy D. VP of Operations | Grant or award · Stock Option | +2,500,000 | 2,500,000 | ||
| 2012-12-07 | Radov A. Jeffrey Director | Grant or award · Stock Option | +10,000,000 | 10,000,000 | ||
| 2012-12-07 | San Antonio Joel Director | Grant or award · Stock Option | +10,000,000 | 10,000,000 |
Page 34 of 35 · 690 trades